Ito C, Ando Y, Akimoto T, Kusano E, Asano Y
Division of Nephrology, Jichi Medical School, Tochigi, Japan.
Nihon Jinzo Gakkai Shi. 2000 Jul;42(5):374-80.
The effect of plasmapheresis(PP) monotherapy and PP with corticosteroid administration were evaluated in a male with crescentic glomerulonephritis(CrGN). On the first admission, since he was positive for both anti-neutrophil cytoplasmic myeloperoxydase autoantibody(MPO-ANCA) and circulating immune complex(IC), the treatment was started with PP alone to reduce these autoantibodies immediately. During two months, three series of PP were performed: three sessions of plasma exchange (PEX) with fresh frozen plasma(FFP), two sessions of double filtration plasmapheresis(DFPP), and then, another two sessions of PEX, respectively. ANCA remained suppressed for 4 weeks after the first series of PEX, and increased thereafter. Subsequent DFPP caused a rebound of ANCA titer while the second PEX suppressed ANCA, at least, for 1 week. Though creatinine clearance(Ccr) improved after the first PEX and this level was maintained, ANCA increased again after the second PEX. Therefore the patient was treated with methyl-prednisolone(m-PSL) semipulse therapy followed by mild cocktail therapy including prednisolone(PSL) at 20 mg/day and mizoribine at 100 mg/day. In two weeks, ANCA and IC became negative and Ccr improved further. When PSL was tapered off, the ANCA became positive again. Since ANCA was not suppressed and Ccr declined gradually even after re-administration of oral PSL at 30-40 mg/day, PP was superimposed on steroid therapy with 3 sessions of DFPP and PEX, respectively. Ccr was improved, but ANCA was not sufficiently decreased by DFPP. Subsequent PEX was more efficient than DFPP in reducing the ANCA level. However, m-PSL semipulse was eventually required for complete suppression of ANCA. Thus PP was partially effective, but not sufficient as monotherapy. However it was considered advantageous as an adjunct therapy to reduce the dose of immunosuppressive drugs in CrGN. As to the mode of PP, PEX with FFP appeared to be more effective than DFPP in reducing the plasma ANCA level.
对一名新月体性肾小球肾炎(CrGN)男性患者评估了血浆置换(PP)单一疗法以及联合使用皮质类固醇的PP疗法的效果。首次入院时,由于他的抗中性粒细胞胞浆髓过氧化物酶自身抗体(MPO - ANCA)和循环免疫复合物(IC)均呈阳性,因此开始单独使用PP以立即降低这些自身抗体。在两个月内,进行了三个系列的PP:三次使用新鲜冰冻血浆(FFP)进行血浆置换(PEX),两次进行双重滤过血浆置换(DFPP),然后再分别进行两次PEX。在首次系列PEX后,ANCA抑制了4周,此后升高。随后的DFPP导致ANCA滴度反弹,而第二次PEX至少将ANCA抑制了1周。尽管首次PEX后肌酐清除率(Ccr)有所改善并维持在该水平,但第二次PEX后ANCA再次升高。因此,该患者接受了甲泼尼龙(m - PSL)半脉冲疗法,随后采用温和的联合疗法,包括每天20 mg泼尼松龙(PSL)和100 mg咪唑立宾。两周内,ANCA和IC转阴,Ccr进一步改善。当逐渐减少PSL剂量时,ANCA再次转为阳性。由于即使重新给予每天30 - 40 mg口服PSL后ANCA仍未被抑制且Ccr逐渐下降,因此在类固醇疗法基础上叠加了PP,分别进行了3次DFPP和PEX。Ccr有所改善,但DFPP未能充分降低ANCA。随后的PEX在降低ANCA水平方面比DFPP更有效。然而,最终需要m - PSL半脉冲疗法才能完全抑制ANCA。因此,PP部分有效,但作为单一疗法并不充分。不过,它被认为作为辅助疗法在减少CrGN中免疫抑制药物剂量方面具有优势。至于PP的方式,使用FFP进行PEX在降低血浆ANCA水平方面似乎比DFPP更有效。